Condensed Consolidated Statements of Operations (Unaudited) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Operating expenses:
Research and development	$ 450	$ 861	$ 1,553	$ 1,792
Sales and marketing	2,129	1,726	4,202	3,245
General and administrative	733	698	2,288	1,568
Restructuring costs	227		227
Fees related to comprehensive settlement agreement		500		500
Total operating expenses	3,539	3,785	8,270	7,105
Loss from operations	(1,561)	(884)	(3,828)	(1,586)
Decrease in fair value of warrant liability	1,121		982
Interest and other income (expense), net	(26)	(5)	(41)	(12)
Net loss	(466)	(889)	(2,887)	(1,598)
Series C redeemable preferred stock accretion	1,144		1,621
Net loss applicable to common stockholders	(1,610)	(889)	(4,508)	(1,598)
Basic and diluted net loss per common share applicable to common stockholders (in Dollars per share)	$ (0.45)	$ (0.32)	$ (1.35)	$ (0.57)
Weighted average shares outstanding for basic and diluted net loss per share applicable to common stockholders (in Shares)	3,591	2,818	3,343	2,815
Recurring [Member]
Revenues:
Total revenues	3,020	2,960	6,186	5,596
Cost of revenues:
Total cost of revenues	694	407	1,366	738
Gross profit:
Total gross profit	2,326	2,553	4,820	4,858
Non-Recurring [Member]
Revenues:
Total revenues	908	1,695	2,114	3,235
Cost of revenues:
Total cost of revenues	1,256	1,347	2,492	2,574
Gross profit:
Total gross profit	(348)	348	(378)	661
Recurring And Non Recurring [Member]
Revenues:
Total revenues	3,928	4,655	8,300	8,831
Cost of revenues:
Total cost of revenues	1,950	1,754	3,858	3,312
Gross profit:
Total gross profit	$ 1,978	$ 2,901	$ 4,442	$ 5,519